Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of Ovid Therapeutics Inc (NASDAQ:OVID) dipped 65.7% to $1.1285 after Takeda’s Skyline study in Dravet syndrome missed…
Pfizer’s COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading Claims
Kansas has filed a lawsuit against Pfizer, Inc., alleging the company misled the public about the safety and effectiveness of its COVID-19 vaccine, resulting in consumer protection violations and record revenues.
12 Consumer Discretionary Stocks Moving In Monday’s Intraday Session
Gainers Aarons (NYSE:AAN) stock increased by 32.5% to $9.99 during Monday’s regular session. The company’s market cap stands…
12 Health Care Stocks Moving In Monday’s Intraday Session
Gainers Mustang Bio (NASDAQ:MBIO) stock moved upwards by 307.9% to $0.53 during Monday’s regular session. The company’s market…
12 Industrials Stocks Moving In Monday’s Intraday Session
Gainers Silynxcom (AMEX:SYNX) stock rose 31.7% to $3.41 during Monday’s regular session. The company’s market cap stands at…
12 Information Technology Stocks Moving In Monday’s Intraday Session
Gainers Quantum (NASDAQ:QMCO) shares rose 20.9% to $0.71 during Monday’s regular session. The company’s market cap stands at…
Why Xponential Fitness Shares Are Surging On Monday
Xponential Fitness announces Mark King as the new CEO effective June 17, 2024, boosting investor confidence. King, with a robust track record at Taco Bell and Adidas, aims to enhance global brand performance and franchise operations.
What’s Going On With Blink Charging Stock?
Blink Charging shares are trading lower Monday, and the stock is down more than 11% over the past five days. Here's a look at what's going on:
Legend Biotech’s Cancer Drug, ‘The Most Attractive Product,’ Set For Growth: Analyst
Legend Biotech analyst predicts growth for Carvykti. The Multiple Myeloma drug could become a $5B+ product.
Why Allego Shares Are Moving Higher Monday
Under the transaction framework agreement, Meridiam will launch a tender offer for all outstanding ordinary shares of Allego that are not owned by Meridiam or its affiliates.